| PERIOD ENDING | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | | Total Revenue | 81,577 | 166,282 | 230,976 | 23,946 | | Cost of Revenue | (112,207) | 143,733 | 196,784 | 280,439 | | | Gross Profit | 193,784 | 22,549 | 34,192 | (256,493) | | | Operating Expenses | | Research Development | 2,766 | 1,052 | 395 |
-
| | Selling General and Administrative | 210,665 | 15,212 | 14,115 | (239,174) | | Non Recurring |
-
|
-
| 5,000 | 861 | | Others | 11,362 | 11,216 | 11,056 | 9,236 | | | | Total Operating Expenses |
-
|
-
| 30,566 |
-
| | | | Operating Income or Loss | (31,009) | (4,931) | 3,626 | (27,416) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 836 | 1,177 | (3,098) | | Earnings Before Interest And Taxes | (31,719) | (6,004) | 4,803 | (28,383) | | Interest Expense | 18,115 | 16,456 | 16,037 | 13,273 | | Income Before Tax | (49,834) | (22,460) | (11,234) | (41,656) | | Income Tax Expense | 748 | 530 | 1,733 | (4,566) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (50,582) | (22,990) | (12,967) | (37,090) | | | Non-recurring Events | | Discontinued Operations | 2,223 | 1,736 | (33,493) | (5,890) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (48,359) | (21,254) | (46,460) | (42,980) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($48,359) | ($21,254) | ($46,460) | ($42,980) |
|
0.67% Nasdaq 
Income Statement
